PDCD1 and cancer: Six patients were allergic to chemotherapeutic agents (procarbazine, oxaliplatin, paclitaxel, and temozolomide), while the other two were allergic to anti-cancer immunotherapeutics targeting programmed cell death-1 (PD-1) or programmed cell death-ligand 1 (PD-L1) [11].